Oxford Cancer Analytics’ $11 Million Series A Investment Round

Taylor Wessing advised Oxford Cancer Analytics Ltd (OXcan) on the deal. Marriott Harrison advised We Venture Capital and Cross-Border Impact Ventures.Oxford Cancer Analytics Ltd (OXcan) completed…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Marco Zingaro

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here